What is Artiva Biotherapeutics, Inc.'s gross unrealized gains?

Artiva Biotherapeutics, Inc. (ARTV) reported gross unrealized gains of $26K in Q1 2026.

How has Artiva Biotherapeutics, Inc.'s gross unrealized gains changed year-over-year?

Artiva Biotherapeutics, Inc.'s gross unrealized gains decreased by 58.1% year-over-year, from $62K to $26K.

What is the long-term trend for Artiva Biotherapeutics, Inc.'s gross unrealized gains?

Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s gross unrealized gains has grown at a -40.8% compound annual growth rate (CAGR), from $308K to $108K.

Artiva Biotherapeutics, Inc. ARTV Gross Unrealized Gains

Gross Unrealized Gains at other companies

Gilead SciencesGILD

——

Allogene TherapeuticsALLO

——

Nektar TherapeuticsNKTR

——

Viridian Therapeutics, Inc.VRDN

——

Other financials

Income statement

See full

Revenue-—

Operating income-$24.4M-10.2%

Net income-$23.5M-15.8%

EPS (diluted)-$0.95-14.5%

Balance sheet

See full

Cash & equivalents$21.4M-30.6%

Total debt$10.3M-26.7%

Total equity$87.8M-48.0%

Total assets$106.0M-44.6%

Cash flow

See full

Operating cash flow-$21.0M-5.6%

CapEx$242.0K-52.6%

Free cash flow-$21.2M-4.1%

Valuation

See full

Market cap$429.03M+1,015%

Enterprise value$417.88M+1,832%

Profitability

See full

Operating margin-83.9%—

Net margin-79.3%—

Returns & leverage

See full

Return on equity-67.9%—

Debt / equity0.1×0.0×

Current ratio8.2×-5.8×

Where this comes from

Reported directly by Artiva Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.

The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artiva Biotherapeutics, Inc.'s gross unrealized gains.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Artiva Biotherapeutics, Inc.'s gross unrealized gains?: Artiva Biotherapeutics, Inc. (ARTV) reported gross unrealized gains of $26K in Q1 2026.
How has Artiva Biotherapeutics, Inc.'s gross unrealized gains changed year-over-year?: Artiva Biotherapeutics, Inc.'s gross unrealized gains decreased by 58.1% year-over-year, from $62K to $26K.
What is the long-term trend for Artiva Biotherapeutics, Inc.'s gross unrealized gains?: Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s gross unrealized gains has grown at a -40.8% compound annual growth rate (CAGR), from $308K to $108K.